ERBB2 and cancer: ADAPT6-ABD-mcDM1 demonstrated nanomolar affinity to HER2, a reasonably good internalization rate by HER2-expressing cancer cells lines, a specific HER2-dependent toxicity in several cancer cell lines, and the capacity for specific accumulation in HER2-expressing human tumor xenografts in mice.